Skip to main content

Covid - 19 Effect : Increased risks of violence against women and girls, exploitation and child marriage

By Unknown

In addition to dropping out of school, education disruption puts girls and young women at increased risk of numerous abuses: child marriage, exploitation, child labor, early pregnancy, and gender-based violence. 

School closures, the loss of protective spaces provided by school, lockdowns spent at home and COVID-19 mitigation measures disrupt children›s routine, and place new stressors on parents and caregivers, contributing to an increase in the severity and frequency of domestic violence across the country.

School closures represent the loss of a safe space, where girls who are experiencing violence and abuse can find respite, and where there is an opportunity for adults to identify signs of abuse and intervene in their lives.


School closures and the socio-economic impact of COVID-19 have increased the risk of reliance on negative coping mechanisms, such as child marriage. With many families losing their means of livelihood, girls are at increased risk of being forced to drop out permanently from school and marry early. 

An increase in reported cases of child marriage within the first few weeks/months of the pandemic has been documented.Out of school, children are also easy targets of abuse, exploitation and recruitment by armed forces and groups, fueling vicious cycles of conflicts and hindering development.


Schools can provide a safe space where children can be protected from violence and crises. When schools reopen, they need to address public health and safety issues comprehensively, to prevent and respond to COVID-19 but also to ensure the safety of students in and around schools. 

Safety measures should include measures to prevent COVID-19, such as facilitating and requiring handwashing, social distancing, and measures to protect teachers and staff, but also help to address other safety issues such how students can travel safely to school, safety from gender-based violence in and around schools, and the lack of health services and social protection for girls.

Comments

Post a Comment

Popular posts from this blog

Increased risks of drop out for women and girls : CoronaVirus Updates

By Unknown
The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...
Post a Comment
Read more

Glenmark's antiviral combination for moderate Covid-19 shows no clinical benefit

By Unknown
Glenmark Pharmaceuticals Ltd on Friday said addition of Umifenovir did not demonstrate any additional benefit over Favipiravir alone in moderate Covid-19 patients. Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment, the trial did not meet key end-points,  the company said. The trial's findings confirm that the addition of Umifenovir does not show any incremental benefit in clinical outcomes, Monika Tandon, senior vice president & head, Clinical Development, Global Specialty/Branded Portfolio at the company, said in a statement , adding that favipiravir alone remains the effective choice for mild to moderate COVID-19 infection. Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014, while Umifenovir is licensed as a treatment for some types of flu infections in Russia and China. Fujifilm last month said a late-stage study of Avigan showed i...
Post a Comment
Read more

No significant benefit of Umifenovir in COVID-19 treatment: Glenmark

By Unknown
Drug firm  Glenmark Pharmaceuticals  on Friday said the addition of  antiviral Umifenovir  did not demonstrate any significant clinical benefit over  Favipiravir  alone in  moderate COVID-19 patients .  The  clinical study  evaluated the possible superiority of the combination's efficacy against Favipiravir monotherapy, Glenmark said in a statement. As per the results that Glenmark presented to the regulator, the study showed no superior clinical outcomes with the addition of Umifenovir, it added. This was the second clinical study after the successful Favipiravir monotherapy trial earlier this year that led the company to receiving the Emergency Use Authorisation for Favipiravir, Glenmark said. "These latest findings confirm that the addition of Umifenovir does not show any incremental benefit in clinical outcomes. Thus Favipiravir therapy along with supportive care remains a suitable and effective choice for mild to moderate COVID-1...
Post a Comment
Read more